| Literature DB >> 34363755 |
Justin Taft1, Michael Markson1, Diana Legarda2, Roosheel Patel1, Mark Chan3, Louise Malle1, Ashley Richardson1, Conor Gruber1, Marta Martín-Fernández1, Grazia M S Mancini4, Jan A M van Laar5, Philomine van Pelt6, Sofija Buta1, Beatrijs H A Wokke7, Ira K D Sabli8, Vanessa Sancho-Shimizu8, Pallavi Pimpale Chavan9, Oskar Schnappauf10, Raju Khubchandani11, Müşerref Kasap Cüceoğlu12, Seza Özen12, Daniel L Kastner10, Adrian T Ting3, Ivona Aksentijevich10, Iris H I M Hollink4, Dusan Bogunovic13.
Abstract
TANK binding kinase 1 (TBK1) regulates IFN-I, NF-κB, and TNF-induced RIPK1-dependent cell death (RCD). In mice, biallelic loss of TBK1 is embryonically lethal. We discovered four humans, ages 32, 26, 7, and 8 from three unrelated consanguineous families with homozygous loss-of-function mutations in TBK1. All four patients suffer from chronic and systemic autoinflammation, but not severe viral infections. We demonstrate that TBK1 loss results in hypomorphic but sufficient IFN-I induction via RIG-I/MDA5, while the system retains near intact IL-6 induction through NF-κB. Autoinflammation is driven by TNF-induced RCD as patient-derived fibroblasts experienced higher rates of necroptosis in vitro, and CC3 was elevated in peripheral blood ex vivo. Treatment with anti-TNF dampened the baseline circulating inflammatory profile and ameliorated the clinical condition in vivo. These findings highlight the plasticity of the IFN-I response and underscore a cardinal role for TBK1 in the regulation of RCD.Entities:
Keywords: IKKE; IRF3; RIPK1; TBK1 deficiency; TNF alpha; autoinflammation; interferon type I; viral susceptibility
Mesh:
Substances:
Year: 2021 PMID: 34363755 PMCID: PMC8380741 DOI: 10.1016/j.cell.2021.07.026
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 66.850